Description
Product Description: Propa-Med Testosteronpropionat Bioniche Pharma
Propa-Med Testosteronpropionat by Bioniche Pharma is a high-quality anabolic steroid designed to enhance muscle growth, strength, and performance. With its potent formulation and reliable reputation, this product is a top choice for bodybuilders and athletes looking to take their training to the next level.
Specific Details and Features:
- Brand: Bioniche Pharma
- Active Ingredient: Testosteronpropionat
- Strength: 100mg/ml
- Quantity: 10ml vial
- Origin: Europe
- Authenticity: Genuine product directly from the manufacturer
Benefits:
- Promotes rapid muscle growth and increased strength
- Enhances protein synthesis for improved recovery and muscle repair
- Boosts nitrogen retention, leading to enhanced muscle density
- Increases red blood cell production, improving endurance and oxygen delivery
- Improves overall athletic performance and power
Possible Side Effects:
- Estrogenic side effects: water retention, gynecomastia (rare with proper dosage)
- Androgenic side effects: oily skin, acne, increased facial/body hair growth
- Suppression of natural testosterone production (temporary, can be managed with post-cycle therapy)
Usage and Dosage:
For beginners:
- Start with a dosage of 50mg every other day
- Gradually increase to 100mg every other day over a 4-6 week period
For experienced bodybuilders:
- Recommended dosage is 100mg every other day
- Cycle duration: 8-12 weeks
Value for Buyers:
When you buy Propa-Med Testosteronpropionat from our online sports pharmacy Steroidspills in the UK, you can expect:
- High-quality, genuine product directly from the manufacturer
- Competitive pricing and special offers
- Discreet packaging and secure delivery
- Responsive customer support to address any queries or concerns
With our commitment to customer satisfaction and the exceptional benefits of Propa-Med Testosteronpropionat, you can trust Steroidspills to provide you with the best products for your bodybuilding journey.
Reviews
There are no reviews yet.